Johnson & Johnson's Income Falls 23%


Health care giant Johnson & Johnson says sales rebounded but its profit dropped 23 percent in the first quarter, due to higher expenses, costs of recalls and litigation and a tax gain that boosted results a year ago.

Adjusted earnings topped expectations. J&J also raised its full-year earnings outlook.

The maker of Band-Aids, baby shampoo and birth control pills posted net income of $3.48 billion, or $1.25 per share, down from $4.53 billion, or $1.62 per share, in 2010's first quarter.

But after two years of declines, revenue rose by 3.5 percent to $16.17 billion.

Adjusted income was $4.86 billion, or $1.35 per share. Analysts expected earnings of $1.03 per share and revenue of $15.6 billion.

Reader Comments (Page 1 of 1)

Symbol Lookup
IndexesChangePrice
DJIA-27.0212,938.67
NASDAQ-15.402,933.17
S&P 500-4.551,357.66

Last updated: February 23, 2012: 02:38 AM

Hot Stocks

General Electric

19.39-0.02(-0.10)

Alcoa

10.38-0.03(-0.29)

Apple Inc

513.04-1.81(-0.35)

Google Inc 'A'

607.94-6.06(-0.99)

Bank of America

7.95-0.16(-1.97)

Wal-Mart Stores

58.60-1.47(-2.45)

Exxon Mobil Corp

86.92+0.35(+0.40)

Ford

12.28-0.25(-2.00)

Citigroup

32.36-1.00(-3.00)

IBM

193.87+0.48(+0.25)

Yahoo

14.50-0.25(-1.69)

Starbucks

48.33+0.07(+0.14)

Microsoft

31.27-0.17(-0.54)

Home Depot

46.57-0.35(-0.75)

DailyFinance Headlines

Benzinga Headlines

TheFlyOnTheWall.com Headlines

    BioHealth Investor Headlines

    WalletPop Headlines

    DailyFinance BlackBerry App

    My Portfolios

    Track your stocks here!

    Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

    BloggingStocks Partners

    More from AOL Money & Finance

    BioHealth Investor Headlines

    Page Loaded in 1329982738976 ms.